Moderna shares fell up to 25% after a data leak for its personalized melanoma vaccine developed with Merck
Business – 5 outletsUnited States
Bloomberg
Moderna, Merck Shares Fall After Possible Melanoma Data Leak
CNBC
Moderna shares plunge after leak of cancer vaccine data despite positive results
Forbes
Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak
MarketWatch
Moderna’s stock tumbles after reported leak of data for cancer vaccine
STAT
STAT+: Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial
STAT+: What to expect from the Moderna-Merck cancer vaccine data reveal